| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |